Supriya Lifescience Limited (BOM:543434)

Supriya Lifescience Revenue

In the fiscal year ending March 31, 2026, Supriya Lifescience had annual revenue of 8.28B INR with 18.86% growth. Supriya Lifescience had revenue of 2.77B in the quarter ending March 31, 2026, with 50.20% growth.

• Revenue: 8.28B
• Revenue Growth: +18.86%
• P/S Ratio: 9.22
• Revenue / Employee: 16.08M
• Employees: 515
• Market Cap: 76.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.28B	1.31B	18.86%
Mar 31, 2025	6.96B	1.26B	22.12%
Mar 31, 2024	5.70B	1.09B	23.73%
Mar 31, 2023	4.61B	-691.11M	-13.04%
Mar 31, 2022	5.30B	1.39B	35.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error